Lao, Al-mufti U.

HRN: 27-64-48  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2025
OXACILLIN 500MG (VIAL)
08/17/2025
08/24/2025
IV
280mg
Q6H
Staphylococcal Skin Infection
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines